These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3023553)

  • 1. Twenty-four hour changes in active and inactive renin after various oral doses of the converting enzyme inhibitor ramipril (HOE498) in normal man.
    Malatino LS; Manhem P; Ball SG; Leckie BJ; Morton JJ; Murray GD; Robertson JI
    J Clin Hypertens; 1986 Sep; 2(3):231-7. PubMed ID: 3023553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers.
    Bussien JP; Nussberger J; Porchet M; Waeber B; Brunner HR; Perisic M; Tansey MJ; Bomm M; Hajdu P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Mar; 329(1):63-9. PubMed ID: 2987705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
    Unger T; Ganten D; Lang RE; Schölkens BA
    J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats.
    Rowland NE; Fregly MJ
    Behav Neurosci; 1988 Dec; 102(6):953-60. PubMed ID: 2850816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ramipril diacid on the peripheral vascular effects of angiotensin I.
    Webb DJ; Collier JG
    Am J Cardiol; 1987 Apr; 59(10):45D-49D. PubMed ID: 2953225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
    Ocón-Pujadas J; Debusmann ER; Jane F; Lahn W; Irmisch R; Mora J; Grötsch H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S45-8. PubMed ID: 2474101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A symposium: Ramipril--a new angiotensin converting enzyme inhibitor. May 2-4, 1986, Brussels, Belgium. Proceedings.
    Am J Cardiol; 1987 Apr; 59(10):1D-177D. PubMed ID: 3034015
    [No Abstract]   [Full Text] [Related]  

  • 9. Converting enzyme inhibitors and brain angiotensin.
    Phillips MI; Kimura B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S82-90. PubMed ID: 2438497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.
    Manhem PJ; Ball SG; Morton JJ; Murray GD; Leckie BJ; Fraser R; Robertson JI
    Br J Clin Pharmacol; 1985 Jul; 20(1):27-35. PubMed ID: 2992562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man.
    MacDonald NJ; Hughes DM; Lees KR; Reid JL
    Br J Clin Pharmacol; 1990 Jul; 30(1):107-13. PubMed ID: 2202384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
    Vasmant D; Bender N
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).
    Unger T; Moursi M; Ganten D; Hermann K; Lang RE
    J Cardiovasc Pharmacol; 1986; 8(2):276-85. PubMed ID: 2422465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
    Böhm RO; van Baak MA; Rahn KH
    Eur J Clin Pharmacol; 1986; 30(5):541-7. PubMed ID: 3019702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension.
    Karlberg BE; Lindström T; Rosenqvist U; Ohman KP
    Am J Cardiol; 1987 Apr; 59(10):104D-109D. PubMed ID: 3034016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers.
    Thuillez C; Richer C; Giudicelli JF
    Am J Cardiol; 1987 Apr; 59(10):38D-44D. PubMed ID: 3034032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril].
    Clauser E
    Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats.
    Unger T; Ganten D; Lang RE; Schölkens BA
    J Cardiovasc Pharmacol; 1985; 7(1):36-41. PubMed ID: 2580148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers.
    Witte PU; Metzger H; Eckert HG; Irmisch R
    Arzneimittelforschung; 1984; 34(10B):1448-51. PubMed ID: 6097272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
    Moursi MG; Ganten D; Lang RE; Unger T
    J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.